{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:17:46Z","timestamp":1768285066140,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:00:00Z","timestamp":1571184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301779\/2009-0"],"award-info":[{"award-number":["301779\/2009-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308311\/2009-4"],"award-info":[{"award-number":["308311\/2009-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["310911\/2009-5"],"award-info":[{"award-number":["310911\/2009-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005243","name":"United Nations Educational, Scientific and Cultural Organization","doi-asserted-by":"publisher","award":["182\/06"],"award-info":[{"award-number":["182\/06"]}],"id":[{"id":"10.13039\/100005243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007225","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.aohep.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T12:24:31Z","timestamp":1571919871000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hepatotoxicity during TB treatment in people with HIV\/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil"],"prefix":"10.1016","volume":"19","author":[{"given":"Carolline","family":"Araujo-Mariz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de F\u00e1tima P.","family":"Milit\u00e3o de Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmundo P.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo A.A.","family":"Ximenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helo\u00edsa R.","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dem\u00f3crito B.","family":"Miranda-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brena B.","family":"Lustosa-Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Filipe P.","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartolomeu","family":"Acioli-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.09.008_bib0180","unstructured":"World Health Organization. Global Tuberculosis Report 2017. Geneva: World Health Organization; 2017."},{"key":"10.1016\/j.aohep.2019.09.008_bib0185","unstructured":"Brasil. Boletim epidemiol\u00f3gico \u2013 Coinfec\u00e7\u00e3o TB-HIV no Brasil: panorama epidemiol\u00f3gico e atividades colaborativas. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; 2017."},{"key":"10.1016\/j.aohep.2019.09.008_bib0190","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis","volume":"365","author":"Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2019.09.008_bib0195","doi-asserted-by":"crossref","first-page":"e0157725","DOI":"10.1371\/journal.pone.0157725","article-title":"Hepatotoxicity during treatment for tuberculosis in people living with HIV\/AIDS","volume":"11","author":"Ara\u00fajo-Mariz","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.aohep.2019.09.008_bib0200","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.tube.2014.03.006","article-title":"The role of cigarette smoking and liver enzymes polymorphisms in anti-tuberculosis drug-induced hepatotoxicity in Brazilian patients","volume":"94","author":"Zaverucha-do-Valle","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.aohep.2019.09.008_bib0205","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1590\/S1806-37132010000500016","article-title":"Antituberculosis drugs: drug interactions, adverse effects, and use in special situations \u2013 Part 1: First-line drugs","volume":"36","author":"Arbex","year":"2010","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.aohep.2019.09.008_bib0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FPC.0000000000000062","article-title":"PharmGKB summary: very important pharmacogene information for N acetyltransferase 2","volume":"24","author":"McDonagh","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.aohep.2019.09.008_bib0215","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcma.2014.01.010","article-title":"Recent progress in genetic variation and risk of antituberculosis drug induced liver injury","volume":"77","author":"Huang","year":"2014","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.aohep.2019.09.008_bib0220","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1007\/s11033-012-2433-y","article-title":"Slow N acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis","volume":"40","author":"Du","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.aohep.2019.09.008_bib0225","first-page":"622","article-title":"NAT2 and CYP 2E1 polymorphisms and susceptibility to first-line anti-tuberculosis drug-induced hepatitis","volume":"14","author":"Lee","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.aohep.2019.09.008_bib0230","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1590\/S0074-02762011000600011","article-title":"Genetic polymorphisms of NAT2 CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients","volume":"106","author":"Teixeira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.aohep.2019.09.008_bib0235","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.2012.05713.x","article-title":"NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients","volume":"39","author":"An","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.aohep.2019.09.008_bib0240","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.patbio.2011.07.001","article-title":"Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity 364 in Tunisian patients with tuberculosis","volume":"60","author":"Ben Mahmoud","year":"2012","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.aohep.2019.09.008_bib0245","unstructured":"Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Manual de recomenda\u00e7\u00f5es para o controle da tuberculose no Brasil. Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica. Bras\u00edlia, Minist\u00e9rio da Sa\u00fade, 2011."},{"key":"10.1016\/j.aohep.2019.09.008_bib0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2156-6-30","article-title":"Inferring haplotypes at the NAT2 locus: the computational approach","volume":"6","author":"Sabbagh","year":"2005","journal-title":"BMC Genet"},{"key":"10.1016\/j.aohep.2019.09.008_bib0255","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2011.04.005","article-title":"Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load","volume":"62","author":"Wang","year":"2011","journal-title":"J Infection"},{"key":"10.1016\/j.aohep.2019.09.008_bib0260","doi-asserted-by":"crossref","first-page":"e47769","DOI":"10.1371\/journal.pone.0047769","article-title":"Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta analysis","volume":"7","author":"Cai","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.aohep.2019.09.008_bib0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpt197518170","article-title":"Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydrazine metabolites","volume":"18","author":"Mitchell","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.aohep.2019.09.008_bib0270","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00228-006-0111-5","article-title":"CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis","volume":"391","author":"Vuilleumier","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.aohep.2019.09.008_bib0275","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tube.2014.02.003","article-title":"Association of NAT2 GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity","volume":"394","author":"Singla","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.aohep.2019.09.008_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008571-200301000-00008","article-title":"Arylamine N-acetyltransferase (NAT2) genotypes in Africans: the identification of a new allele with nucleotide changes 481C>T and 590G>A","volume":"13","author":"Dandara","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.aohep.2019.09.008_bib0285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/138920008784892155","article-title":"Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms","volume":"9","author":"Garc\u00eda-Mart\u00edn","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.aohep.2019.09.008_bib0290","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.5588\/ijtld.10.0648","article-title":"N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians","volume":"15","author":"Leiro-Fernandez","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.aohep.2019.09.008_bib0295","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12863-014-0156-x","article-title":"Distribution of allele and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population","volume":"15","author":"Guaoua","year":"2014","journal-title":"BMC Genet"},{"key":"10.1016\/j.aohep.2019.09.008_bib0300","doi-asserted-by":"crossref","first-page":"e83926","DOI":"10.1371\/journal.pone.0083926","article-title":"Association of genetic variants with self-assessed color categories in Brazilians","volume":"9","author":"Durso","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.aohep.2019.09.008_bib0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","article-title":"Color and genomic ancestry in Brazilians","volume":"100","author":"Parra","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.aohep.2019.09.008_bib0310","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mrfmmm.2007.03.015","article-title":"Genetic profile of the arylamine N-acetyltransferase 2 coding gene among individuals from two different regions of Brazil","volume":"624","author":"Teixeira","year":"2007","journal-title":"Mutat Res"},{"key":"10.1016\/j.aohep.2019.09.008_bib0315","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2156-11-87","article-title":"Interethnic diversity of NAT2 polymorphisms in Brazilian admixed populations","volume":"11","author":"Talbot","year":"2010","journal-title":"BMC Genet"},{"key":"10.1016\/j.aohep.2019.09.008_bib0320","doi-asserted-by":"crossref","first-page":"499","DOI":"10.5588\/ijtld.12.0645","article-title":"N-acetyl transferase 2 and cytochrome P450 2E1 genes and isoniazid-induced hepatotoxicity in Brazilian patients","volume":"17","author":"Santos","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.aohep.2019.09.008_bib0325","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00228-008-0484-8","article-title":"Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil","volume":"64","author":"Possuelo","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.aohep.2019.09.008_bib0330","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF03262213","article-title":"Genetic interaction between NAT2, GSTM1, GSTT1 CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs","volume":"16","author":"Costa","year":"2012","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.aohep.2019.09.008_bib0335","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/17425250902877698","article-title":"emerging concepts serve as a paradigm for understanding complexities of personalized medicine","volume":"5","author":"Hein","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.aohep.2019.09.008_bib0340","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","article-title":"Risk factors for idiosyncratic drug-induced liver injury","volume":"138","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2019.09.008_bib0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00008571-200104000-00004","article-title":"Functional characterization of human N-acetyltransferase 2 (NAT2) single nucleotide polymorphisms","volume":"11","author":"Fretland","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.aohep.2019.09.008_bib0350","doi-asserted-by":"crossref","DOI":"10.1109\/TBME.2019.2897285","article-title":"Severe dengue prognosis using human genome data and machine learning","author":"Davi","year":"2019","journal-title":"IEEE Trans Biomed Eng"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119322598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:39:24Z","timestamp":1761647964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119322598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1665268119322598"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.008","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatotoxicity during TB treatment in people with HIV\/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}